| Trial ID: | L6293 |
| Source ID: | NCT00728156
|
| Associated Drug: |
Clopidogrel
|
| Title: |
Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Coronary Artery Disease
|
| Interventions: |
DRUG: clopidogrel|DRUG: placebo
|
| Outcome Measures: |
Primary: To compare the effect of Clopidogrel in reduction of thrombogenicity in patients with T2DM and CAD with placebo, seven days | Secondary: To identify patients (in particular T2DM patients with CAD) resistant to oral antiplatelet therapy, seven days|To characterise features in T2DM patients responsible for increased thrombogenicity, seven days
|
| Sponsor/Collaborators: |
Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Collaborators: British Heart Foundation|University of Newcastle Upon-Tyne
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
90
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-08
|
| Completion Date: |
2012-04
|
| Results First Posted: |
|
| Last Update Posted: |
2015-10-12
|
| Locations: |
Newcastle Diabetes Centre, Newcastle General Hospital, Newcastle upon Tyne, Tyne and Wear, NE4 6BE, United Kingdom|Freeman Hospital, Newcastle upon Tyne, Tyne and Wear, NE77DN, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT00728156
|
